Armistice Capital LLC Grows Stake in DENTSPLY SIRONA Inc. $XRAY

Armistice Capital LLC grew its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 27.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,298,000 shares of the medical instruments supplier’s stock after purchasing an additional 1,562,000 shares during the period. DENTSPLY SIRONA makes up 1.0% of Armistice Capital LLC’s portfolio, making the stock its 12th biggest holding. Armistice Capital LLC’s holdings in DENTSPLY SIRONA were worth $83,416,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in XRAY. AQR Capital Management LLC grew its position in shares of DENTSPLY SIRONA by 109.8% during the 2nd quarter. AQR Capital Management LLC now owns 13,316,771 shares of the medical instruments supplier’s stock valued at $211,470,000 after purchasing an additional 6,970,086 shares in the last quarter. Jacobs Levy Equity Management Inc. grew its position in shares of DENTSPLY SIRONA by 662.0% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 4,608,341 shares of the medical instruments supplier’s stock valued at $58,480,000 after purchasing an additional 4,003,606 shares in the last quarter. Goldman Sachs Group Inc. grew its position in shares of DENTSPLY SIRONA by 827.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier’s stock valued at $36,378,000 after purchasing an additional 2,172,343 shares in the last quarter. Marshall Wace LLP grew its position in shares of DENTSPLY SIRONA by 1,032.5% during the 4th quarter. Marshall Wace LLP now owns 2,236,786 shares of the medical instruments supplier’s stock valued at $25,566,000 after purchasing an additional 2,039,280 shares in the last quarter. Finally, Brickwood Asset Management LLP grew its position in shares of DENTSPLY SIRONA by 5,515.8% during the 3rd quarter. Brickwood Asset Management LLP now owns 1,524,074 shares of the medical instruments supplier’s stock valued at $19,340,000 after purchasing an additional 1,496,935 shares in the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. Zacks Research upgraded shares of DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a research report on Monday, March 2nd. Barclays reduced their price target on shares of DENTSPLY SIRONA from $12.00 to $9.00 and set an “underweight” rating for the company in a research report on Thursday, June 4th. Bank of America raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $13.00 to $17.00 in a report on Thursday, February 19th. Weiss Ratings downgraded shares of DENTSPLY SIRONA from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 6th. Finally, Robert W. Baird lifted their price objective on shares of DENTSPLY SIRONA from $12.00 to $14.00 and gave the stock a “neutral” rating in a report on Friday, February 27th. Three investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, DENTSPLY SIRONA presently has an average rating of “Hold” and an average price target of $13.55.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ:XRAY opened at $10.03 on Thursday. The company has a market cap of $2.01 billion, a price-to-earnings ratio of -3.18, a price-to-earnings-growth ratio of 1.24 and a beta of 0.89. The company has a 50-day moving average price of $10.90 and a 200-day moving average price of $11.69. The company has a current ratio of 1.53, a quick ratio of 0.98 and a debt-to-equity ratio of 1.52. DENTSPLY SIRONA Inc. has a 12 month low of $9.40 and a 12 month high of $17.09.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Tuesday, May 5th. The medical instruments supplier reported $0.27 EPS for the quarter, missing the consensus estimate of $0.28 by ($0.01). The firm had revenue of $880.00 million for the quarter, compared to the consensus estimate of $841.80 million. DENTSPLY SIRONA had a negative net margin of 17.06% and a positive return on equity of 18.83%. The business’s revenue was up .1% on a year-over-year basis. During the same period last year, the company posted $0.43 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, equities analysts anticipate that DENTSPLY SIRONA Inc. will post 1.42 EPS for the current year.

Insider Activity

In other news, Director Brian P. Mckeon acquired 10,000 shares of the stock in a transaction dated Friday, June 12th. The stock was purchased at an average cost of $10.12 per share, with a total value of $101,200.00. Following the completion of the purchase, the director owned 10,000 shares in the company, valued at approximately $101,200. The trade was a ∞ increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Brian T. Gladden acquired 9,985 shares of the stock in a transaction dated Monday, June 15th. The shares were purchased at an average cost of $10.02 per share, with a total value of $100,049.70. Following the completion of the purchase, the director owned 61,849 shares of the company’s stock, valued at approximately $619,726.98. The trade was a 19.25% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last ninety days, insiders bought 35,160 shares of company stock valued at $351,179. Insiders own 0.46% of the company’s stock.

DENTSPLY SIRONA Company Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.